Ji Lin

3PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 07, 2024
A seamless phase II/III design with dose optimization for oncology drug development.

Yuhan Li, Yiding Zhang, Gu Mi

|Apr 12, 2018
A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer.

Johanna C Bendell, Anna M Varghese, David M Hyman

Pageof 1